Celltrion | 068270 - EPS Earnings Per Share

Stock Price
188,800.00
Daily Change
-6,300.00 -3.23%
Monthly
-9.67%
Yearly
22.60%
Q2 Forecast
177,698.56

Celltrion reported KRW1.58K in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1576.11 1216.07 481.37 May/06
FY2025Q4 Dec/2025 2285.89 1401.69 481.37 Feb/05
FY2025Q3 Sep/2025 1128.22 998.38 388.00 Oct/21
FY2025Q2 Jun/2025 810.39 918.69 361.54 Jul/21
FY2025Q1 Mar/2025 481.37 966.11 69.90 May/09




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Avita Medical AUD -0.38 0 Dec/2025
Celltrion KRW 1.58K 709.78 Mar/2026
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
IQVIA Holdings USD 2.9 0.52 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Organon & Co USD 0.71 0.08 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026